JNCE

Q: What is the price of Jounce Therapeutics (JNCE) today?

The price of Jounce Therapeutics (JNCE) today is $ 0.00, with return of 0% compared to the last year. The price of Jounce Therapeutics (JNCE) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Jounce Therapeutics (JNCE) and international markets.

Q: When does Jounce Therapeutics (JNCE) pay dividends?

Jounce Therapeutics (JNCE) did not distribute dividends in the last year.

Q: Is Jounce Therapeutics (JNCE) worth it?

Currently, Jounce Therapeutics (JNCE) is priced at $ 0.00, with a P/E of 1.10%, representing a deviation of -532% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Jounce Therapeutics (JNCE) stock?

Investing in stocks of Jounce Therapeutics (JNCE) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Jounce Therapeutics (JNCE) yield today?

The yield of Jounce Therapeutics (JNCE) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Jounce Therapeutics (JNCE) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Jounce Therapeutics Inc.

Price

$ -

return (12m)

0.00%

p/e

1.10

p/bv

0.53

DIVIDEND YIELD

0.00%

price JNCE

JNCE

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of JNCE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals JNCE

review the fundamentals of Jounce Therapeutics shares

P/E

1.10

Sector: -3.74 Industry: -3.74

P/SALES RATIO (PSR)

Sector: -3.71 Industry: -3.71

P/BV

0.53

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

41.53%

Sector: -63.91% Industry: -63.91%

ROE

48.21%

Sector: -67.36% Industry: -67.36%

ROIC

Sector: -1,129.15% Industry: -1,129.15%

NET MARGIN

100.00%

Sector: -41.63% Industry: -41.63%

GROSS MARGIN

100.00%

Sector: 39.39% Industry: 39.39%

OPERATING MARGIN

-18.02%

Sector: -41.51% Industry: -41.51%

P/EBITDA

1.11

Sector: -3.78 Industry: -3.78

P/EBIT

1.11

Sector: -3.91 Industry: -3.91

P/ASSET

0.46

Sector: 1.49 Industry: 1.49

BVPS

3.54

Sector: 1.73 Industry: 1.73

EPS

1.71

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.86

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

5.64%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF Jounce Therapeutics ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals JNCE

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	20.28	0.00	0.00%	2.43%	$ 509.48 B	27.26%
PFE	15.06	1.59	10.56%	6.61%	$ 147.98 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	13.80	7.96	57.70%	3.53%	$ 212.69 B	32.78%
MRK	13.09	0.00	0.00%	3.25%	$ 249.10 B	29.63%
AZN	29.76	6.09	20.45%	1.74%	$ 279.74 B	16.17%
BMY	17.58	5.71	32.47%	4.76%	$ 106.18 B	12.57%
GILD	18.58	7.02	37.80%	2.59%	$ 150.68 B	27.88%
ZTS	19.83	9.74	49.11%	1.69%	$ 52.56 B	28.21%
HALO	12.44	14.70	118.17%	0.00%	$ 7.41 B	47.91%
REGN	16.32	2.41	14.79%	0.49%	$ 74.71 B	32.13%
AMGN	25.34	18.45	72.82%	2.85%	$ 177.48 B	19.47%
VRTX	31.73	6.73	21.22%	0.00%	$ 116.60 B	31.35%
MCK	24.84	-173.31	-697.75%	0.37%	$ 100.18 B	1.04%
CAH	29.67	-17.33	-58.40%	1.02%	$ 47.32 B	0.68%
ADMA	22.65	11.00	48.57%	0.00%	$ 4.74 B	42.87%
BIIB	16.57	1.46	8.83%	0.00%	$ 26.65 B	15.98%
HRMY	12.44	2.77	22.24%	0.00%	$ 2.31 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

JNCE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Jounce Therapeutics

Jounce Therapeutics Inc.

Average user rating I10

4.0 (0 people)

United States

13 years

Founded: 2012

2017

Time since IPO - 8 years

128

Employees

The Company Jounce Therapeutics Inc. (United States), is listed on Nasdaq with a market value of $ 97.18 Millions, having an equity of $ 183.11 Millions.

With a total of 128 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 82.00 Millions, which generated a profit in the amount of $ 88.28 Millions.

As for its main indicators, the Company has a P/E ratio of 1.10, a P/BV ratio of 0.53 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker JNCE.

Market cap

$ 97.18 Millions

Net worth

$ 183.11 Millions

US$ 183,112,000.00

Assets

$ 212.55 Millions

US$ 212,550,000.00

Total Shares Outstanding

51.69 Millions

51,694,000

Average Daily Trading Volume

$ 3.15 Millions

US$ 3,150,104.00

Sector

Health Care

Industry

Biotechnology

JNCE

JNCE revenue and profits

Financial Results JNCE

DRAG THE FRAME TO SEE MORE DATA

JNCE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 813.80 41,98% (12M)

P/E

24.84

0.37%

ROE

-697.75%

P/BV

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12M)

P/E

29.67

1.02%

ROE

-58.40%

P/BV

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12M)

P/E

20.28

2.43%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12M)

P/E

13.09

3.25%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.85 9,78% (12M)

P/E

15.06

6.61%

ROE

10.56%

P/BV

1.59

ABBV - AbbVie

$ 223.32 34,34% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12M)

P/E

29.76

1.74%

ROE

20.45%

P/BV

6.09

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 813.80 41,98% (12 M)

P/L

24.84

0.37%

ROE

-697.75%

P/VP

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12 M)

P/L

29.67

1.02%

ROE

-58.40%

P/VP

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12 M)

P/L

20.28

2.43%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12 M)

P/L

13.09

3.25%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.85 9,78% (12 M)

P/L

15.06

6.61%

ROE

10.56%

P/VP

1.59

ABBV - AbbVie

$ 223.32 34,34% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12 M)

P/L

29.76

1.74%

ROE

20.45%

P/VP

6.09

Frequently Asked Questions

What is the price of Jounce Therapeutics (JNCE) today?

The price of Jounce Therapeutics (JNCE) today is $ 0.00, with return of 0% compared to the last year. The price of Jounce Therapeutics (JNCE) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Jounce Therapeutics (JNCE) and international markets.

When does Jounce Therapeutics (JNCE) pay dividends?

Jounce Therapeutics (JNCE) did not distribute dividends in the last year.

Is Jounce Therapeutics (JNCE) worth it?

Currently, Jounce Therapeutics (JNCE) is priced at $ 0.00, with a P/E of 1.10%, representing a deviation of -532% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Jounce Therapeutics (JNCE) stock?

Investing in stocks of Jounce Therapeutics (JNCE) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Jounce Therapeutics (JNCE) yield today?

The yield of Jounce Therapeutics (JNCE) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Jounce Therapeutics (JNCE) today, the total investment would be $ 0.00, based on the current price of $ 0.00.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.00
In 5 years: $ 0.00
In 10 years: $ 0.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

JNCE

Jounce Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of JNCE

review the fundamentals of Jounce Therapeutics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Jounce Therapeutics

Jounce Therapeutics Inc.

United States

13 years

2017

128

Financial Results JNCE

JNCE cash flow

asset growth - JNCE

JNCE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions